Conference Information

Scientific Sessions
Market Analysis

Scientific Sessions

Cancer is a disease that is caused when cells in the body divide in an uncontrollable manner. This result in production/growth of accumulated mass of cells or lump which are called tumours. The branch of biology dealing with prevention, diagnosis and treatment of cancer or tumours is called cancer biology. Till now, more than 200 types of cancer have been discovered. Cancer is classified based on the origin of tumour cells. There are various biochemical, genetic and environmental factors that contribute in development of cancer. It can be caused by genetic defects that are passed on generation to generation. Most cancer cases occur due to genetic mutations resulting from irregular lifestyle, obesity and other environmental factors. Some viruses are also causative agents of cancer such as Herpes virus and Human Papillomavirus. Some autoimmune diseases are also linked with cancer such as Crohn disease and celiac disease. Cancerous cells are of two types-benign and malignant. Benign tumour cells do not spread to other parts of the body. Malignant tumour cells have the potential to invade other cells or spread other parts of the body and this is called metastasis.

Related Conferences: The Summit on National & Global Cancer Health Disparities, April 27- 28, 2019, Washington, US | 3^rd International Cancer Conference and Expo, June 05- 07, 2019, Baltimore, US | International Symposium on Supportive Care in Cancer 2019, June 21- 23, 2019, San Francisco, US | 4^th EACR Conference on Cancer Genomics, June 23- 26, 2019, Cambridge, UK | Gordon Research Conference-Cancer Nanotechnology, June 23- 28, 2019, Vermont, US | New Treatments and Technologies in Thoracic Oncology Conference, June 24, 2019, London, UK | International Conference on Cancer Biology and Anti-Cancer Therapies, June 24- 25, 2019, Singapore | 2^nd Cologne Conference on Lung Cancer, June 26- 27, 2019, Cologne, Germany.

Session 2 Cancer Screening and Diagnostics

In most of the cases, there is no apparent symptoms or sign of cancer growth in the body. Signs and symptoms of cancer appear in form of cell mass, lump or ulcer. Symptoms and signs of cancerous growth in the body depend on the type and origin of cancer. There are other symptoms too that may or may not be related to cancer such as unusual weight loss, fever, weakness, fatigue, sore throat, persistent cough, nausea, unusual bleeding or discharge, loss of appetite and others. Generally imaging study of the affected area is performed with the help of X-rays, CT, MRI, Ultrasound. Endoscopy and some blood test are also performed to detect the abnormalities.

Related Conferences: 7^th International Conference on Advances in Haematology and Oncology, June 29 - 30, 2019, Seattle, US | Gordon Research Conference- Translational Cancer Genomics, Jun 30 - July 05, 2019, Hong Kong, China | 2^nd International Conference on Oncology and Haematology, July 04- 06, 2019, Brussels, Belgium | International Conference on Cancer Science & Stem cell Research, July 29- 30, 2019, Amsterdam, Netherlands | Gordon Research Conference-Hormone-Dependent Cancers, August 04- 09, 2019, Maine, US | 5^th International Congress on Epigenetics & Chromatin, Augusts 22- 23, 2019, Vienna, Austria | Advanced Prostate Cancer Consensus Conference, August 29- 31, 2019, Basel, Switzerland | Nanotechnology in Cancer: Engineering for Oncology, September 12 - 14, 2019, Cambridge, UK.

Session 3 Organ Specific Cancers

Various types of cancers are classified based on site of origin or affected tissues or cells such as Carcinoma, Sarcoma, Lymphoma, Leukemia, Myeloma and Mixed type cancer. Breast cancer, liver cancer, colorectal cancer, cervical cancer, lung cancer and pancreatic cancer are some of the organ specific cancers. More than 100 types of cancers affect humans. Several types of cancer are formed in liver in which hepatocellular carcinoma is the most common type. Colorectal cancer is formation of cancerous cells in colon (large intestine) or rectal; it is also called bowel cancer. Cervical cancer is cancer arising from cervix. Human papillomavirus is the main causative agent in development of the cervical cancer. It is the fourth most common cause of death from cancer in women.

Related Conferences: Euro Cancer Research Conference, September 12 -14, 2019, Rome, Italy | 2^nd Indo-Oncology Summit, September 13 – 14, 2019, Bhubaneswar, Odisha, India | 6^th Asia Pacific Congress of Interventional Oncology, October 02- 05, 2019, Kuala Lumpur, Malaysia | 2^nd Annual Advances in Immuno-Oncology USA Congress, October 08 – 09, 2019, San Diego, US | Scripps Cancer Care Symposium October 11 - 12 , 2019, San Diego, USA | 8^thInter-American Oncology Conference on Current Status and Future of Anti-Cancer Therapies, October 17- 18 ,2019, Buenos Aires, Argentina | 15^th Annual Psychosocial Oncology Symposium: Clinical Use of Cannabis in Cancer Care, June 14, 2019, Washington, US | Current Concepts in Head and Neck & Endocrine Pathology, June 12-15, 2019, Boston, US.

Session 4 Cancer Bioinformatics

Cancer bioinformatics is concerned with the application of bioinformatics methods and computational tools to understand the biochemical metabolism, molecular mechanism of oncogene and proto-oncogene’s regulation and signalling pathway of cancer. The field is also associated with the identification and validation of novel network biomarkers and personalized medicines in prevention and treatment of cancer.

Related Conferences: Advances in Screening, Detection, and Treatment of Prostate Cancer, June 14- 15, 2019, New York, US | North American Symposium on Late Complications After Childhood Cancer, June 20- 22, 2019, Atlanta, US | Palliative Care Symposium for Advanced Practice Providers, June 22, 2019, New York, US | The 7^thInternational Conference on Advances in Haematology and Oncology, June 29- 30, 2019, Washington, US | Breast Cancer: New Horizons, Current Controversies, July 11- 13, 2019, Boston, US | Women Oncology & Nursing Care, July 19- 20, 2019, Atlanta, US | 5^th Annual Breast Cancer Conference, July 26, 2019, Morgantown, US | Head and Neck Cancer Survivorship Symposium, August 05- 06, 2019 , Pittsburgh, US.

Session 5 Cancer Biomarkers

Cancer biomarkers refer to a molecule or substance secreted by the body in response to presence of tumour cells in the body. Biomarkers are used to identify early stage cancer, or to diagnose the disease condition of patient. It can also be used to define the predictive treatment or monitor the treatment process given to the patients.

Related Conferences: Haematology and Medical Oncology Best Practices, August 15- 22, 2019, Vermont, US | American Society for Radiation Oncology Annual Meeting, September 15- 18, 2019, Chicago, US | 34^th Annual Critical Issues in Tumour Microenvironment: Angiogenesis, Metastasis and Immunology, September 16- 19, 2019, Charlestown, US | Basic Science of Immunotherapy, September 20, 2019, Scottsdale, US | Individualizing Medicine Conference: Precision Cancer Care through Immunotherapy and Genomics, September 20- 21, 2019, Scottsdale, US | 10^th Annual Comprehensive Haematology & Oncology Review Course, September 21- 24, 2019, Washington, US | Biology of Cancer: Microenvironment & Metastasis, September 24- 28, 2019, NY, US | International Thoracic Surgical Oncology Summit, September 27- 28, 2019, New York, US.

Session 6 Cancer Epidemiology

It can be defined as the study of identification of carcinogenic factors and cause of cancer. There are many cancer-causing factors such as irregular lifestyle, obesity, tobacco smoking, alcohol consumption. Other factors known to affect cancer risks are exposure to the radiations and chemicals. Some hormones too, can cause the development of cancer by promoting abnormal cell proliferation such as insulin like growth factors and their binding proteins.

Related Conferences: 4^th Annual Cutaneous Oncology Symposium 2019, September 27- 28, 2019, Orlando, US | North American Neuroendocrine Tumour Society Annual Symposium , October, 03- 05, 2019 Boston, US | Acute and Chronic Leukemia 2019, October 11- 12, 2019, Coronado, United States | Symposium on Clinical Interventional Oncology, October 11- 13, 2019, US | Molecular Diagnostics: Current Roles in Cancer Diagnosis and Patient Management, October 19- 20, 2019 Boston, US | Society for Integrative Oncology 16^thInternational Conference, October 19- 21, 2019, New York, US | 12^th International Congress on Myeloproliferative Neoplasms, October 24- 25, 2019, New York City, US | 34^th Annual Meeting of the Society for Immunotherapy of Cancer, November 06- 10, 2019, National Harbour, US.

Session 7 Cancer Epigenetics and Oncogenomics

Cancer epigenetics is the study of heritable changes in gene activity or expression without altering the nucleotide sequences in the genetic material. Examples of these types of changes include DNA methylation and histone modification.in different types of cancer. A variety of epigenetic modifications can be applied such as silencing of tumour suppressor genes or activation of oncogenes, histone modification or dysregulation of DNA binding proteins.

Oncogenomics is a sub-field of genomics that deals with the characterization of cancer associated genes. More specifically, it focuses on the genomic, epigenomic and transcriptomic alterations in cancer. It also deals with the identification of novel tumour suppressing genes that may be used to find new treatment approach.

Related Conferences: 15^thInternational Conference on Malignant Lymphoma, June 18- 22, 2019, Lugano, Switzerland | Interdisciplinary Approach to the Diagnosis and Treatment of Breast Cancer, September 17, 2019, Novi Beograd, Serbia | 6^th Asia Pacific Congress of Interventional Oncology, October 02- 05, 2019, Kuala Lumpur, Malaysia | World Congress on Gastrointestinal Cancer, July 03 – 06, 2019, Barcelona, Spain | 2019 Japanese Society of Medical Oncology Annual Meeting, July 18 – 20, Kyoto, Japan | 39^th Congress of the European Society of Surgical Oncology, October 09 – 11 , 2019, Rotterdam, The Netherlands | Gordon Research Seminar: Overcoming Endocrine Resistance and Metastasis in Hormone-Dependent Cancers, August 03- 04, 2019, Maine, US | European Cancer Summit, September 12- 14, Brussels, Belgium.

Session 8 Cancer Treatment and Therapies

Cancer treatments and therapies vary based on type of cancer a person is suffering from. The major treatments are surgery, radiotherapy, chemotherapy, immunotherapy, hormonal therapy, targeted therapy, laser therapy, palliative care, stem cell transplant and precision medicine. There are also some vaccines to treat a certain type of cancer such as Human papillomavirus vaccine, hepatitis B vaccine.

Related Conferences: 5^th International Cancer Immunotherapy Conference, September 25- 28, 2019, Paris, France | European Society for Medical Oncology 2019 Congress, September 27- October 01, 2019, Vienna, Austria | Global Congress on Prostate Cancer, October 23- 24, 2019, Paris, France | 20^th Asia Pacific Prostate Cancer Conference, September 24- 26, 2019, Melbourne, Australia | Cancer Stem Cells: Advances in Biology & Clinical Translation, October 13- 17, 2019, Hong Kong, China | Global experts meeting on Frontiers in Breast Cancer and Therapy, July 15- 17 , 2019, London, UK | 5^th World Congress on Controversies in Breast Cancer, September 04- 06, 2019, San Francisco, USA | World Summit on Breast Cancer, August 19- 20, 2019, Amsterdam, Netherlands.

Session 9 Alternative Cancer Treatments

Alternative cancer treatments do not play a direct role in treatment of cancer, rather they may be useful to reduce the sign and symptoms of cancerous cells. Common signs and symptoms that a cancer patient feels such as unusual weight loss, extreme fatigue, nausea and vomiting, pain, anxiety, sore throat, persistent cough, unusual bleeding or discharge, loss of appetite, etc can be reduced by these treatments. Some of the alternative treatments are exercise, meditation, music therapy, aromatherapy, hypnosis, acupuncture, massage relaxation techniques, and yoga.

Related Conferences: Global Conference on Breast Cancer Research, September 02- 03, 2019, Rome, Italy | American Society of Colon and Rectal Surgeons Annual Scientific Meeting 2019, June 01- 05, Cleveland, Ohio | Association of Coloproctology Of Great Britain And Ireland Annual Conference, Dublin, July 01- 03, 2019, Dublin, Ireland | European Society of Surgical Oncology 39^th Congress 2019, October 09- 11, 2019, Rotterdam | IASLC 2019 World Conference on Lung Cancer, September 07 – 10, 2019, Barcelona, Spain | IASLC 2019 North America Conference on Lung Cancer , October 10 – 12, 2019 , Chicago

Session 10 Robotic Oncology

Robotic oncology is an advanced form of cancer treatment in which oncologist perform a robot-assisted minimally invasive or laparoscopic surgery to treat cancer such as prostate, liver, stomach, colon as well as some gynaecologic cancers.

Related Conferences: Georgia Blood Cancer Conference, Atlanta, September 07, 2019 | Wisconsin Blood Cancer Conference, September 21, 2019, Wisconsin | New York/New Jersey Blood Cancer Conference , October 5, 2019, New York | Pennsylvania Blood Cancer Conference, November 02, 2019, Pennsylvania | 5^th International Conference on Acute Myeloid Leukemia, October 24- 26, 2019, Estoril, Portugal | European Haematology Association 24^th Congress 2019, June 13 - 16, 2019, Amsterdam, Netherlands | New Insights Into the Understanding of Thrombosis & Haemorrhage in Myeloproliferative Neoplasms : Improving Patient Outcomes , June 27- 28, 2019, Charleston, US | International Society for Experimental Haematology Annual Scientific Meeting, 2019, August 22- 25, 2019, Brisbane , Australia.

Session 11 Pediatric Oncology

Paediatric oncology is a branch of medicine concerned with the diagnosis and treatment of cancer in children. The most common cancer in children are leukemia, or blood cancer and lymphoma. Children with cancer are affected with cognitive and learning problems. The type of cancer that develop in children are often different from cancers that develop in adults.

Related Conferences: Ash meeting on Hematologic Malignancies 2019, September 06 - 07, 2019, Chicago, US | Society of Hematologic Oncology 7^th Annual Meeting 2019, September 11- 14, 2019, Texas, US | National Comprehensive Cancer Network 14th Annual Congress: Hematologic Malignancies 2019, September 27- 28, 2019, San Francisco, US | 5^th International Conference on New Concepts in Lymphoid Malignancies, October 03- 05, 2019, Estoril, Portugal | 10^th international Eurasian Haematology Oncology Congress, October 09- 12, 2019, Istanbul, Turkey | Japanese Society of Haematology 81^st annual meeting 2019, October 11- 13, 2019, Tokyo, Japan | Italian Society of Haematology 2019, October 07- 09, 2019, Rome, Italy | Haematology Society of Australia and New Zealand, The Australian & New Zealand Society of Blood Transfusion and the Australasian Society of Thrombosis and Haemostasis 2019, October 20- 23, 2019, Perth, Australia.

Session 12 Oncology Nursing and Palliative Care

Oncology nursing is the meeting the various needs of cancer patients during the diagnosis screening, and treatment of cancer. Well trained oncology nurses are employed for this work.

Palliative care is the treatment provided to cancer patients to feel better and it can be a combination of variety of methods. The goal of palliative care is reducing the symptoms of cancer and improving the quality of life.

Related Conferences: 12^th Congress on Myeloproliferative Neoplasms 2019, October 24- 25, 2019, New York city, US | Australian and New Zealand Society for Palliative Medicine, Medical and Surgical Update 2019 ,July 26- 27, 2019, Melbourne, Australia | 26^th Cancer Genomics Congress: New Era for Cancer Prevention, July 15- 16, 2019, Abu Dhabi, UAE | International Conference on Biomarkers and Clinical Research, July 19- 20, 2019, Abu Dhabi, UAE | 34^th Euro-Global Summit on Cancer Therapy & Radiation Oncology, July 25- 27, 2019, London, UK | 37^th World Cancer Conference, October 09-10, 2019, Dublin, Ireland | 31^st International Conference on Cancer Research Therapy, September 09- 10, 2019 Zurich, Switzerland | International Conference on Biomarkers and Cancer Targets, October 21- 22, 2019 , Abu Dhabi, UAE.

Session 13 Innovations in Cancer Research and Oncology

Cancer is the one of the deadliest diseases in the world today. There are various types of treatments available to prevent or treat cancer. It is also called group of diseases. In major cases, survival rates are very low.

Current innovations in cancer research are:

Implantation of radioactive elements at the site of malignant tumour: brain cancer, cervical, prostate and other cancers.
Precision cancer medicine administration
Nutraceuticals application
Stem-cell therapy
Nanomedicine
Computational imaging of pathology (radiomics and pathomics)
RNA based transcriptome study
Dynamic BH3 profiling

Related Conferences: International Conference on Molecular Markers and Cancer Therapeutics, October 14- 15, 2019, Abu Dhabi, UAE | European Meet on Cancer Research & Therapy, October 21- 22, 2019 Lisbon, Portugal | 15^th World Congress on Blood Cancer, October 21- 22, 2019 ,Prague, Czech Republic | 4^th World Congress on Frontiers in Cancer Research and Therapy, October 21- 22, 2019, Melbourne, Australia | 3^rd International Meeting on Women’s Health and Breast Cancer, October 24- 25, 2019, New Zealand | Spanish Society of Medical Oncology National Congress 2019, October 22- 25, 2019, Pamplona, Spain.

Session 14 Anti-Cancer Drug Discovery and Development

Continuous Anticancer drug discovery and development is critical to find a complete cure for cancer. Due to the drug resistance developed by tumour cells for existing treatments, this is becoming a mandatory approach to fight the disease.

Various kinase enzymes are important in control of cell growth and the replication cycle. These can act as regulators of cell division checkpoints to ensure the integrity of DNA replication through sensing DNA damage and initiating repair, while halting cell cycle. Many cancerous cells are deficient in DNA damage checkpoints due to deletion or mutation in p53 pathway. This provides an opportunity to selectively target tumour cells to enhance the ionization effect or widely used DNA damaging cancer chemotherapies.
Scientific investigation on inhibitors of checkpoint CHK1 can be another milestone for anticancer drug discovery approach.
Cancer cells are specifically dependent on molecular chaperones and related proteins that regulate homeostasis. These are promising targets for new anticancer therapies.
Deregulated apoptosis is hallmark of cancer and Bcl-2 family of proteins are pivotal to mediating the pathway of this process. Inhibiting their process can e a significant way for developing new anticancer drugs. Many plant sources are known to be valuable sources of novel anti-cancer properties

Session 15 Cancer Pharmacology

Cancer pharmacology encompasses study of basic mechanisms of signal transduction associated with cell proliferation and apoptosis, mechanism of actions of new anti-tumour agents and discovery of new drugs, Basic mechanism of DNA damage and DNA repairs and development of novel strategies for gene therapy. It also includes investigation on role of growth factors in the progression of tumours and identification of new signal transduction pathway and new receptors. Other areas of cancer pharmacology research include aberrations in the mechanisms of programmed cell deaths associated with tumoral growth, genes associated with tumoral growth, interleukin therapy, free radical generation and chemotherapeutic resistance.

Session 16 Cancer Medical Reports

Cancer medical reports contain a complete information about diagnosis and prescribed medications based on cancer type and severity of disease. It also has description about the origin of disease or tumour shape size, colour and affected tissue or area. Cancer medical reports also describe about the laboratory tests and other diagnostic tools a cancer patient has undergone to.

Session 17 Regenerative Medicine

It is the branch of medicine deals with process of regrowth, repair or replace the diseased cells It also includes generation and use of therapeutic stem cells, tissue engineering and production of artificial organs or tissues. Example of regenerative medicine include the use of extracellular matrix materials in treatments of chronic wounds and orthopaedic surgeries, and transplantation of in vitro grown cells, tissues and organs.

Session 18 Cancer Management, Treatment and Prevention

Cancer is a disease occurs due to abnormal cell division in the body. The abnormal cell proliferation occurs as a result of absence of cell division signal regulators. In other terms, cancerous cells lack the molecular components that instruct them to stop dividing uncontrollably and to die. The various chemical, cellular and environmental factors induce the tumour growth in the body. Exposure to certain substances have been linked to development of cancer such as smoking, excessive alcohol consumption, irregular lifestyle, obesity, exposure to radiation and infection with oncoviruses. Some cancers are also caused by inherited genetic defects. Some hormones play an important role by promoting abnormal cell proliferation. Also, few autoimmune diseases are linked with cancer.

Factors causing cancer can be controlled and therefore, cancer is generally preventable. Greater than 30% of deaths from cancer can be prevented by avoiding risk factors such as tobacco, excess weight or obesity, poor diet and physical inactivity, unsafe sexual mating, and air pollution. Not all environmental causes are preventable, such as exposure to radiation and cancer caused through hereditary genetic defects.

Market Analysis

Cancer is the leading cause of death worldwide and there were about 2.5 million people diagnosed with cancer in 2015 in UK, which is estimated to rise to 4 million by 2030. As the disease has engulfed millions of lives globally till now, prevention and early detection is pre-requisite to stop this disease.

It is estimated that, global anticancer drugs market would expand to US$155.6 billion by 2025 with a CAGR of 6-7% within the forecast period of 2017 to 2025. It is also predicted that, on the basis of cancer type, lung cancer would expand with a CAGR of over 6%. It is also estimated that, global oncology drugs market would witness a CAGR of 7.0% during the forecast period 2018–2024. Based on the regional analysis, it is also predicted that North America would lead oncology drugs market growth followed by Europe, Asia Pacific, and Rest of the World.

A recent report shows that, about 15 oncology therapeutic drugs were launched for 17 indications in 2018. It also shows that global cancer therapy market is estimated to be valued at USD 220,701.26 million in 2024, witnessing a CAGR of 8.37%, where, the target therapy segment is predicted to show a CAGR of about 9.68%.

Why London?

London, one of the most important global cities, is the capital and the largest city of England and UK. It is one of the most visited, expensive and influential cities which is full of fun and Sparkles in November. November in London is also the month of the London Jazz Festival, Hyde Park's Winter Wonderland, South Bank Wintertime, Hogwarts in the Snow and Christmas at Kew and it is also the month when the Christmas lights start to glow, ice rinks begin appearing and festive markets start popping up.

London has got a number of leading educational institutions and is also a major global centre of higher education teaching and research. It has got the largest concentration of higher education institutes in Europe. London has also got many leading cancer centres that offers the most advanced cancer treatments available in the world today.

29^th International Conference on
Cancer and Oncology

Quick Links

Theme: Exploring Advancements in Cancer Research & Oncology

Conference Information

Scientific Sessions

Market Analysis